novo nordisk oral semaglutide brand name Nordisk's weight-loss pill wins FDA approval Novo Nordisk Wins EU Approval
Description
Nausea in the mornings, some digestive upset after larger meals
Imaging 55 (5), 253256
For process development and drug product teams, the extended dosing interval signals a higher peptide payload per unit dose than weekly comparators
Skin and Hair Effects: Increased oil production in skin can lead to acne and oily skin
But the key finding is that orforglipron still provided dramatically better weight maintenance than stopping treatment entirely
2019;35(2):e3104
